165 related articles for article (PubMed ID: 17700520)
21. Modeling human breast cancer metastasis in mice: maspin as a paradigm.
Shi HY; Zhang W; Liang R; Kittrell F; Templeton NS; Medina D; Zhang M
Histol Histopathol; 2003 Jan; 18(1):201-6. PubMed ID: 12507299
[TBL] [Abstract][Full Text] [Related]
22. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
[TBL] [Abstract][Full Text] [Related]
23. Multiple functions of maspin in tumor progression and mouse development.
Zhang M
Front Biosci; 2004 Sep; 9():2218-26. PubMed ID: 15353283
[TBL] [Abstract][Full Text] [Related]
24. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
[TBL] [Abstract][Full Text] [Related]
25. Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2010 Feb; 183(3):455-61. PubMed ID: 19944674
[TBL] [Abstract][Full Text] [Related]
26. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
Alvarez Secord A; Darcy KM; Hutson A; Huang Z; Lee PS; Jewell EL; Havrilesky LJ; Markman M; Muggia F; Murphy SK
Gynecol Oncol; 2011 Nov; 123(2):314-9. PubMed ID: 21903246
[TBL] [Abstract][Full Text] [Related]
27. Quercetin induces gadd45 expression through a p53-independent pathway.
Yoshida T; Maeda A; Horinaka M; Shiraishi T; Nakata S; Wakada M; Yogosawa S; Sakai T
Oncol Rep; 2005 Nov; 14(5):1299-303. PubMed ID: 16211300
[TBL] [Abstract][Full Text] [Related]
28. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
29. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
Zhang M; Shi Y; Magit D; Furth PA; Sager R
Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
[TBL] [Abstract][Full Text] [Related]
30. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
Lara H; Wang Y; Beltran AS; Juárez-Moreno K; Yuan X; Kato S; Leisewitz AV; Cuello Fredes M; Licea AF; Connolly DC; Huang L; Blancafort P
J Biol Chem; 2012 Aug; 287(35):29873-86. PubMed ID: 22782891
[TBL] [Abstract][Full Text] [Related]
31. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
Abramovitch S; Werner H
Horm Metab Res; 2003; 35(11-12):758-62. PubMed ID: 14710355
[TBL] [Abstract][Full Text] [Related]
32. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
[TBL] [Abstract][Full Text] [Related]
33. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
34. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
35. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
36. Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
Zou Z; Zhang W; Young D; Gleave MG; Rennie P; Connell T; Connelly R; Moul J; Srivastava S; Sesterhenn I
Clin Cancer Res; 2002 May; 8(5):1172-7. PubMed ID: 12006534
[TBL] [Abstract][Full Text] [Related]
37. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
38. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
39. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis.
Li Z; Shi HY; Zhang M
Oncogene; 2005 Mar; 24(12):2008-19. PubMed ID: 15688005
[TBL] [Abstract][Full Text] [Related]
40. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
